BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2020903)

  • 1. Serosal invasion as the single prognostic indicator in stage IIIA (T3N1M0) gastric cancer.
    Abe S; Shiraishi M; Nagaoka S; Yoshimura H; Dhar DK; Nakamura T
    Surgery; 1991 May; 109(5):582-8. PubMed ID: 2020903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate prognostic study on large gastric cancer.
    Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
    J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer.
    Hyung WJ; Noh SH; Yoo CH; Huh JH; Shin DW; Lah KH; Lee JH; Choi SH; Min JS
    World J Surg; 2002 Mar; 26(3):323-9. PubMed ID: 11865369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.
    Yasuda K; Shiraishi N; Inomata M; Shiroshita H; Izumi K; Kitano S
    Hepatogastroenterology; 2007; 54(79):2028-31. PubMed ID: 18251153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node metastasis and surgical management of gastric cancer invading the esophagus.
    Yonemura Y; Tsugawa K; Fonseca L; Fushida S; Matsumoto H; Ninomiya I; Sugiyama K; Fujimura T; Nishimura G; Miwa K
    Hepatogastroenterology; 1995 Feb; 42(1):37-42. PubMed ID: 7782032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of the prognosis of gastric cancer with extensive serosal invasion using left upper abdominal evisceration.
    Isozaki H; Tanaka N; Fujii K; Tanigawa N; Okajima K
    Hepatogastroenterology; 2001; 48(40):1179-82. PubMed ID: 11490828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of lymphovascular invasion in patients with stage I gastric cancer.
    Kunisaki C; Makino H; Kimura J; Takagawa R; Kosaka T; Ono HA; Akiyama H; Fukushima T; Nagahori Y; Takahashi M
    Surgery; 2010 Feb; 147(2):204-11. PubMed ID: 19878963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perigastric lymph node status as a prognostic indicator in patients with gastric cancer.
    Adachi Y; Suematsu T; Shiraishi N; Tanimura H; Morimoto A; Kitano S
    Br J Surg; 1998 Sep; 85(9):1281-4. PubMed ID: 9752878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
    Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
    Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The most important prognostic factors for 736 patients with adenocarcinoma of the gastric cardia: a multivariate analysis using COX proportion hazard model].
    Li J; Zhang R; Zhang D
    Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):134-6. PubMed ID: 9206048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J; Ikeguchi M; Nakamura S; Kaibara N
    J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma).
    Isozaki H; Fujii K; Nomura E; Mabuchi H; Nishiguchi K; Hara H; Tanigawa N
    Hepatogastroenterology; 1999; 46(28):2669-72. PubMed ID: 10522062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients.
    Wang JY; Hsieh JS; Huang CJ; Huang YS; Huang TJ
    J Surg Oncol; 1996 Sep; 63(1):36-40. PubMed ID: 8841464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is tumor size a prognostic indicator for gastric carcinoma?
    Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
    Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature.
    Aurello P; D'Angelo F; Rossi S; Bellagamba R; Cicchini C; Nigri G; Ercolani G; De Angelis R; Ramacciato G
    Am Surg; 2007 Apr; 73(4):359-66. PubMed ID: 17439029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Oro S; Tatebe S; Tsujitani S; Ikeguchi M
    Am J Surg; 2006 Sep; 192(3):296-300. PubMed ID: 16920421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.